The Scientific Research Team at KalVista Pharmaceuticals is dedicated to the discovery and development of small molecule protease inhibitors. This collaborative group of research chemists, medicinal chemists, and scientists focuses on designing and synthesizing new compounds, conducting in vitro and in vivo studies, and advancing promising candidates through preclinical and clinical evaluation to address a range of diseases.
View all